Skip to main content
Fig. 1 | Chinese Medicine

Fig. 1

From: Liushen Capsules, a promising clinical candidate for COVID-19, alleviates SARS-CoV-2-induced pulmonary in vivo and inhibits the proliferation of the variant virus strains in vitro

Fig. 1

The antiviral activities of LS against 501Y.V2/B.1.35 strain and the G/478K.V1/ B.1.617.2 strain. A The inhibitory effects of LS on the 501Y.V2/B.1.35 strain in Vero E6 cells. B The inhibitory effects of remdesivir on the 501Y.V2/B.1.35 strain in Vero E6 cells. C The inhibitory effects of LS on the G/478K.V1/ B.1.617.2 strain in Vero E6 cells. D The inhibitory effects of remdesivir on the G/478K.V1/ B.1.617.2 strain in Vero E6 cells. E Inhibitory effect of LS (2 μg/mL, 1 μg/mL and 0.5 μg/mL) on plaque formation of the 501Y.V2/B.1.35 strain. F Inhibitory effect of LS (2 μg/mL, 1 μg/mL and 0.5 μg/mL) on plaque formation of the G/478K.V1/ B.1.617.2 strain

Back to article page

Chinese Medicine

ISSN: 1749-8546

Contact us